CLSD · Categories · Form 4
CLSD - SEC Form 4 insider transactions
Clearside Biomedical Inc. (CLSD) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for CLSD
- SEC Form 4 filed by Chief Financial Officer Deignan Charles A.4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4 filed by Chief Medical Officer Chong Ngai Hang Victor4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4 filed by CEO Lasezkay George M4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4 filed by Director Croarkin Richard4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4 filed by Director Gibney Anthony S4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4 filed by Director Edwards Jeffrey L4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4 filed by Director Hutson Nancy J4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4 filed by Director Yerxa Benjamin R4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4 filed by Director Shaffer Christy L4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4 filed by Director Humphries William D.4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4 filed by Director Thorp Clay4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4 filed by Gibney Anthony S4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4 filed by Chong Ngai Hang Victor4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- Lasezkay George M sold $22,860 worth of shares (18,000 units at $1.27), decreasing direct ownership by 4% to 466,577 units (SEC Form 4)4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- Deignan Charles A. sold $16,512 worth of shares (12,900 units at $1.28), decreasing direct ownership by 3% to 384,662 units (SEC Form 4)4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4: Humphries William D. exercised 22,727 shares at a strike of $0.40, increasing direct ownership by 80% to 51,040 units4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4 filed by Deignan Charles A.4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4 filed by Lasezkay George M4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4: Deignan Charles A. exercised 34,090 shares at a strike of $0.40, increasing direct ownership by 9% to 397,562 units4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4 filed by Thorp Clay4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4 filed by Croarkin Richard4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4 filed by Edwards Jeffrey L4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4 filed by Humphries William D.4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4 filed by Hutson Nancy J4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4 filed by Shaffer Christy L4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4 filed by Yerxa Benjamin R4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4: Ciulla Thomas sold $20,139 worth of shares (13,700 units at $1.47) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 291,890 units to satisfy withholding tax4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4: Lasezkay George M sold $29,244 worth of shares (20,030 units at $1.46) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 484,577 units (tax liability)4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4: Deignan Charles A. sold $21,045 worth of shares (14,030 units at $1.50) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 363,472 units (withholding tax)4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4: Ciulla Thomas sold $3,515 worth of shares (2,170 units at $1.62) as part of a pre-agreed trading plan, decreasing direct ownership by 0.71% to 305,590 units (tax withholding)4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4 filed by Lasezkay George M4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4 filed by Deignan Charles A.4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4: Ciulla Thomas was granted 10,000 shares, increasing direct ownership by 3% to 307,760 units4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4: Thorp Clay bought $14,266 worth of shares (14,000 units at $1.02), increasing direct ownership by 85% to 30,522 units4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4: Deignan Charles A. exercised 23,636 shares at a strike of $0.40, increasing direct ownership by 7% to 377,502 units4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4: Thorp Clay disposed of 1,406,507 shares and acquired 8,522 shares, increasing direct ownership by 107% to 16,522 units4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4: Thorp Clay sold $145,627 worth of shares (32,873 units at $4.43) as part of a pre-agreed trading plan, decreasing direct ownership by 0.66% to 4,951,547 units (Amendment)4/A - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4: Hutson Nancy J bought $39,900 worth of shares (30,000 units at $1.33), increasing direct ownership by 57% to 83,000 units4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4 filed by Shaffer Christy L4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4 filed by Yerxa Benjamin R4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4 filed by Hutson Nancy J4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4 filed by Croarkin Richard4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4 filed by Edwards Jeffrey L4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4 filed by Humphries William D.4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4 filed by Thorp Clay4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4 filed by Yerxa Benjamin R4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4: Ciulla Thomas was granted 46,250 shares, increasing direct ownership by 18% to 301,810 units (Amendment)4/A - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4: Deignan Charles A. was granted 46,250 shares, increasing direct ownership by 15% to 362,699 units (Amendment)4/A - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4: Deignan Charles A. was granted 43,750 shares and sold $18,461 worth of shares (8,833 units at $2.09) as part of a pre-agreed trading plan, increasing direct ownership by 11% to 351,366 units to satisfy withholding tax4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4: Ciulla Thomas was granted 43,750 shares and sold $19,276 worth of shares (9,050 units at $2.13) as part of a pre-agreed trading plan, increasing direct ownership by 16% to 295,260 units (for withholding tax)4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4: Lasezkay George M was granted 97,500 shares and sold $22,896 worth of shares (10,800 units at $2.12) as part of a pre-agreed trading plan, increasing direct ownership by 21% to 504,607 units to cover taxes4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4: Lasezkay George M sold $12,546 worth of shares (5,100 units at $2.46) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 417,907 units (tax liability)4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4: Humphries William D. exercised 22,727 shares at a strike of $0.15, increasing direct ownership by 407% to 28,313 units4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4: Hutson Nancy J exercised 40,000 shares at a strike of $2.03, increasing direct ownership by 308% to 53,000 units4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4: Ciulla Thomas sold $16,384 worth of Common Stock (2,560 units at $6.40), decreasing direct ownership by 0.99% to 255,560 units (tax withholding)4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4: Lasezkay George M sold $22,772 worth of Common Stock (3,525 units at $6.46), decreasing direct ownership by 0.83% to 423,007 units to cover withholding tax4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4: Deignan Charles A. sold $17,948 worth of Common Stock (2,800 units at $6.41), decreasing direct ownership by 0.88% to 316,449 units (tax liability)4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4: Whitmore Bradford T sold $2,920,427 worth of Common Stock (420,285 units at $6.95)4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4: Hutson Nancy J bought $17,040 worth of Common Stock (3,000 units at $5.68), increasing direct ownership by 30% to 13,000 units4 - Clearside Biomedical, Inc. (0001539029) (Issuer)
- SEC Form 4: LASEZKAY GEORGE M sold $16,237 worth of Common Stock (3,707 units at $4.38), decreasing direct ownership by 0.86% to 426,532 units to satisfy withholding obligation4 - Clearside Biomedical, Inc. (0001539029) (Issuer)